Commonwealth Biotechnologies, Tripos deal

CBTE will acquire TRPS's Tripos Discovery Research Ltd. subsidiary for $350,000 up front and up to $1.8 million in later payments. TRPS terminated an earlier agreement to sell the subsidiary to Provid Pharmaceuticals Inc. (North Brunswick, N.J.) (see BioCentury, Jan. 3). ...